Biocon has received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine in that country.   The ...

 Non-communicable diseases like cardiovascular, diabetes and cancer can cost the Indian economy a whopping $6.2 trillion during the 2012-2030 ...

 Dr Sheela CN, head of the obstetrics department at St. Johns Medical College Hospital in Bengaluru, seems pleased with a new product she's ...

 The economy of the 20th century was driven by machines which replaced human toil. We, in India, missed that golden opportunity. But the economy ...

 GSK Consumer Healthcare, the world's leading over-the-counter (OTC) healthcare and wellness products maker, is shifting its priority focus in ...

 The vaccine was launched in Odisha as the state records high diarrhoea cases among children and deaths due to improper Aiming to slash the ...

 Medtronic’s new Micra Transcatheter Pacing System, a leadless pacemaker recently approved by the US Food and Drug Administration, is ...